Neurobiology of Disease, 0969-9961

Journal

More filtering options
  1. Ventral tegmental area dopamine neurons are resistant to human mutant alpha-synuclein overexpression.

    Maingay, M., Romero-Ramos, M., Carta, M. & Deniz Kirik, 2006, In : Neurobiology of Disease. 23, 3, p. 522-532

    Research output: Contribution to journalArticle

  2. Translational approach for gene therapy in epilepsy: Model system and unilateral overexpression of neuropeptide Y and Y2 receptors.

    Nikitidou, L., Esbjörn Melin, Christiansen, S. H., Gøtzsche, C. R., Cifra, A., Woldbye, D. P. D. & Merab Kokaia, 2016, In : Neurobiology of Disease. 86, nov 19, p. 52-61

    Research output: Contribution to journalArticle

  3. Transcriptome analysis in a rat model of L-DOPA-induced dyskinesia

    Konradi, C., Jenny Westin, Carta, M., Eaton, ME., Kuter, K., Dekundy, A., Lundblad, M. & Angela Cenci Nilsson, 2004, In : Neurobiology of Disease. 17, 2, p. 219-236

    Research output: Contribution to journalArticle

  4. The impact of graft size on the development of dyskinesia following intrastriatal grafting of embryonic dopamine neurons in the rat.

    Lane, E., Winkler, C., Brundin, P. & Angela Cenci Nilsson, 2006, In : Neurobiology of Disease. 22, 2, p. 334-345

    Research output: Contribution to journalArticle

  5. The anti-dyskinetic effect of dopamine receptor blockade is enhanced in parkinsonian rats following dopamine neuron transplantation.

    Shin, E., Lisci, C., Tronci, E., Fidalgo, C., Stancampiano, R., Anders Björklund & Carta, M., 2014, In : Neurobiology of Disease. 62, p. 233-240

    Research output: Contribution to journalArticle

  6. Testicular degeneration in Huntington disease

    Van Raamsdonk, J. M., Murphy, Z., Selva, D. M., Hamidizadeh, R., Pearson, J., Åsa Petersén, Maria Björkqvist, Muir, C., Mackenzie, I. R., Hammond, G. L., Vogl, A. W., Hayden, M. R. & Leavitt, B. R., 2007, In : Neurobiology of Disease. 26, 3, p. 512-520

    Research output: Contribution to journalArticle

  7. Targeted expression of BCL-2 attenuates MPP+ but not 6-OHDA induced cell death in dopaminergic neurons

    O'Malley, KL., Liu, J., Lotharius, J. & Holtz, W., 2003, In : Neurobiology of Disease. 14, 1, p. 43-51

    Research output: Contribution to journalArticle

  8. Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

    Anders Björklund, Rosenblad, C., Winkler, C. & Deniz Kirik, 1997, In : Neurobiology of Disease. 4, 3-4, p. 186-200

    Research output: Contribution to journalReview article

  9. Spreading of α-synuclein in the face of axonal transport deficits in Parkinson's disease: A speculative synthesis.

    Lamberts, J. T., Hildebrandt, E. & Brundin, P., 2015, In : Neurobiology of Disease. 77, Jul 15, p. 276-283

    Research output: Contribution to journalReview article

  10. Special Issue: Viral delivery of genes: new frontiers Introduction

    Kordower, J. H. & Deniz Kirik, 2012, In : Neurobiology of Disease. 48, 2, p. 151-152

    Research output: Contribution to journalDebate/Note/Editorial

  11. Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease.

    Shin, E., Garcia, J., Winkler, C., Anders Björklund & Carta, M., 2012, In : Neurobiology of Disease. 47, 3, p. 393-406

    Research output: Contribution to journalArticle

  12. Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function.

    Buck, K., Landeck, N., Ulusoy, A., Majbour, N. K., El-Agnaf, O. M. A. & Deniz Kirik, 2015, In : Neurobiology of Disease. 78, Mar 25, p. 100-114

    Research output: Contribution to journalArticle

  13. Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease

    Febbraro, F., Gurdal Sahin, Farran, A., Soares, S., Jensen, P. H., Deniz Kirik & Romero-Ramos, M., 2013, In : Neurobiology of Disease. 56, p. 47-58

    Research output: Contribution to journalArticle

  14. Rodent models of impulsive compulsive behaviors in Parkinson's disease: how far have we reached?

    Angela Cenci Nilsson, Veronica Francardo, O'Sullivan, S. S. & Lindgren, H., 2015, In : Neurobiology of Disease. 82, aug 29, p. 561-573

    Research output: Contribution to journalReview article

  15. Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline.

    Månsson, R., Magnus Hansson, Morota, S., Uchino, H., Christine Ekdahl Clementson & Eskil Elmer, 2007, In : Neurobiology of Disease. 25, p. 198-205

    Research output: Contribution to journalArticle

  16. Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice.

    Gil, J., Mohapel, P., Araujo, I., Popovic, N., Jia-Yi Li, Brundin, P. & Åsa Petersén, 2005, In : Neurobiology of Disease. 20, 3, p. 744-751

    Research output: Contribution to journalArticle

  17. Reconstruction of brain circuitry by neural transplants generated from pluripotent stem cells.

    Thompson, L. & Anders Björklund, 2015, In : Neurobiology of Disease. 79, Apr 22, p. 28-40

    Research output: Contribution to journalReview article

  18. Proteomic signatures of brain regions affected by tau pathology in early and late stages of Alzheimer's disease

    Mendonça, C. F., Magdalena Kuras, Fábio César Sousa Nogueira, Plá, I., Hortobágyi, T., Csiba, L., Palkovits, M., Renner, É., Döme, P., György Marko-Varga, Domont, G. B. & Melinda Rezeli, 2019, In : Neurobiology of Disease. 130, 104509.

    Research output: Contribution to journalArticle

  19. Progressive nigrostriatal terminal dysfunction and degeneration in the engrailed1 heterozygous mouse model of Parkinson's disease.

    Nordström, U., Beauvais, G., Ghosh, A., Pulikkaparambil Sasidharan, B. C., Lundblad, M., Fuchs, J., Joshi, R. L., Lipton, J. W., Roholt, A., Medicetty, S., Feinstein, T. N., Steiner, J., Escobar Galvis, M. L., Prochiantz, A. & Brundin, P., 2015, In : Neurobiology of Disease. 73, p. 70-82

    Research output: Contribution to journalArticle

  20. Progressive neurodegenerative and behavioural changes induced by AAV-mediated overexpression of α-synuclein in midbrain dopamine neurons.

    Decressac, M., Mattsson, B., Lundblad, M., Weikop, P. & Anders Björklund, 2012, In : Neurobiology of Disease. 45, 3, p. 939-953

    Research output: Contribution to journalArticle

  21. Prion-like seeding and nucleation of intracellular amyloid-β

    Tomas T. Olsson, Oxana Klementieva & Gunnar K. Gouras, 2018 May 1, In : Neurobiology of Disease. 113, p. 1-10 10 p.

    Research output: Contribution to journalArticle

  22. Parkinson's disease-like burst firing activity in subthalamic nucleus induced by AAV-α-synuclein is normalized by LRRK2 modulation

    Michael Aagaard Andersen, Christensen, K. V., Badolo, L., Smith, G. P., Jeggo, R., Jensen, P. H., Andersen, K. J. & Sotty, F., 2018 Aug, In : Neurobiology of Disease. 116, p. 13-27 15 p.

    Research output: Contribution to journalArticle

  23. Optogenetic inhibition of chemically induced hypersynchronized bursting in mice.

    Fredrik Berglind, Marco Ledri, Sørensen, A. T., Nikitidou, L., Melis, M., Bielefeld, P., Deniz Kirik, Deisseroth, K., My Andersson & Merab Kokaia, 2014, In : Neurobiology of Disease. 65, p. 133-141

    Research output: Contribution to journalArticle

  24. Neuroinflammation in the generation of post-transplantation dyskinesia in Parkinson's disease.

    Lane, E., Soulet, D., Vercammen, L., Angela Cenci Nilsson & Brundin, P., 2008, In : Neurobiology of Disease. 32, p. 220-228

    Research output: Contribution to journalArticle

  25. Nerve growth factor promotes survival of new neurons in the adult hippocampus.

    Frielingsdorf, H., Simpson, D. R., Thal, L. J. & Pizzo, D. P., 2007, In : Neurobiology of Disease. 26, 1, p. 47-55

    Research output: Contribution to journalArticle

  26. l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation

    Picconi, B., Paille, V., Ghiglieri, V., Bagetta, V., Barone, I., Lindgren, H., Bernardi, G., Angela Cenci Nilsson & Calabresi, P., 2008, In : Neurobiology of Disease. 29, 2, p. 327-335

    Research output: Contribution to journalArticle

  27. Kindling alters entorhinal cortex-hippocampal interaction by increased efficacy of presynaptic GABA(B) autoreceptors in layer III of the entorhinal cortex

    Gloveli, T., Behr, J., Dugladze, T., Zaal Kokaia, Merab Kokaia & Heinemann, U., 2003, In : Neurobiology of Disease. 13, 3, p. 203-212

    Research output: Contribution to journalArticle

  28. Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain

    Cederfjäll, E., Gurdal Sahin & Deniz Kirik, 2012, In : Neurobiology of Disease. 48, 2, p. 222-227

    Research output: Contribution to journalReview article

  29. Interactions of A beta with endogenous anti-inflammatory agents: a basis for chronic neuroinflammation in Alzheimer's disease.

    Sabina Janciauskiene, Sun, Y. & Wright, H. T., 2002, In : Neurobiology of Disease. 10, 3, p. 187-200

    Research output: Contribution to journalReview article

  30. Inflammation without neuronal death triggers striatal neurogenesis comparable to stroke.

    Chapman, K., Ge, R., Emanuela Monni, Tatarishvili, J., Henrik Ahlenius, Andreas Arvidsson, Ekdahl, C., Olle Lindvall & Zaal Kokaia, 2015, In : Neurobiology of Disease. 83, Aug 20, p. 1-15

    Research output: Contribution to journalArticle

  31. Increased metabolism in the R6/2 mouse model of Huntington's disease.

    van der Burg, J. M., Karl Bacos, Wood, N. I., Andreas Lindqvist, Nils Wierup, Woodman, B., Wamsteeker, J., Ruben Smith, Tomas Deierborg, Kuhar, M. J., Bates, G. P., Hindrik Mulder, Charlotte Erlanson-Albertsson, Morton, J., Brundin, P., Åsa Petersén & Maria Björkqvist, 2008, In : Neurobiology of Disease. 29, 1, p. 41-51

    Research output: Contribution to journalArticle

  32. Increased levels of cocaine and amphetamine regulated transcript in two animal models of depression and anxiety.

    Wiehager, S., Beiderbeck, D. I., Gruber, S. H. M., El-Khoury, A., Wamsteeker, J., Neumann, I. D., Åsa Petersén & Mathé, A. A., 2009, In : Neurobiology of Disease. 34, p. 375-380

    Research output: Contribution to journalArticle

  33. Heritability and genetic variance of dementia with Lewy bodies

    International Parkinson's Disease Genomics Consortium (IPDGC), Guerreiro, R., Elisabet Londos & Bras, J., 2019, In : Neurobiology of Disease. 127, p. 492-501 10 p.

    Research output: Contribution to journalArticle

  34. Genetically determined susceptibility to neurodegeneration is associated with expression of inflammatory genes

    Maria Swanberg, Duvefelt, K., Diez, M., Hillert, J., Olsson, T., Piehl, F. & Lidman, O., 2006, In : Neurobiology of Disease. 24, 1, p. 67-88 22 p.

    Research output: Contribution to journalArticle

  35. Gene therapy for Parkinson's disease: Disease modification by GDNF family of ligands

    Deniz Kirik, Cederfjäll, E., Halliday, G. & Petersén, 2017 Jan 1, In : Neurobiology of Disease. 97, p. 179-188 10 p.

    Research output: Contribution to journalReview article

  36. Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.

    Nishant Narayanan Vaikath, Majbour, N. K., Paleologou, K. E., Ardah, M. T., van Dam, E., van de Berg, W. D. J., Forrest, S. L., Parkkinen, L., Gai, W-P., Hattori, N., Takanashi, M., Lee, S-J., Mann, D. M. A., Imai, Y., Halliday, G. M., Jia-Yi Li & El-Agnaf, O. M. A., 2015, In : Neurobiology of Disease. 79, p. 81-99

    Research output: Contribution to journalArticle

Previous 1 2 Next